Published in J Urol on July 01, 1991
Urethral hypermobility after anti-incontinence surgery - a prognostic indicator? Int Urogynecol J Pelvic Floor Dysfunct (2006) 0.88
Oxidation of nitrogen oxides by bound dioxygen in hemoproteins. J Inorg Biochem (1981) 2.77
Kinetics and mechanism of the oxidation of human deoxyhemoglobin by nitrites. J Biol Chem (1981) 2.29
Combination of Goldman risk and initial cardiac troponin I for emergency department chest pain patient risk stratification. Acad Emerg Med (2001) 2.13
[Revised guideline 'Vasectomy' from the Dutch Urological Association]. Ned Tijdschr Geneeskd (2005) 1.41
Myotonic dystrophy. Predictive value of normal results on clinical examination. Brain (1991) 1.24
Leukocytes in the urine after intravesical BCG treatment for superficial bladder cancer. A flow cytofluorometric analysis. Urol Res (1991) 1.17
Fenoldopam for hypertensive emergencies. Acad Emerg Med (1995) 1.07
Serial creatine kinase-MB results are a sensitive indicator of acute myocardial infarction in chest pain patients with nondiagnostic electrocardiograms: the second Emergency Medicine Cardiac Research Group Study. Acad Emerg Med (1997) 1.05
Risk of postoperative septic complications after abdominal surgical treatment in relation to perioperative blood transfusion. Surg Gynecol Obstet (1990) 1.03
Treatment of superficial bladder tumors: achievements and needs. The EORTC Genitourinary Group. Eur Urol (2000) 1.01
A comparison of blind nasotracheal and succinylcholine-assisted intubation in the poisoned patient. Ann Emerg Med (1987) 1.00
The clinical and urodynamic effects of anterior vaginal repair and Burch colposuspension. Am J Obstet Gynecol (1988) 0.97
Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma. J Urol (1991) 0.97
Intravesical chemotherapy and immunotherapy: how do we assess their effectiveness and what are their limitations and uses? Int J Urol (1995) 0.89
Intravesical BCG in patients with carcinoma in situ of the urinary bladder: long-term results of EORTC GU Group phase II protocol 30861. Eur Urol (2001) 0.87
Multicenter study of creatine kinase-MB use: effect on chest pain clinical decision making. Acad Emerg Med (1996) 0.87
Reference values for amino acids in cerebrospinal fluid of children determined using ion-exchange chromatography with fluorimetric detection. Clin Chim Acta (1989) 0.86
Blinded and uniform causes of death verification in cancer screening: a major influence on the outcome of a prostate cancer screening trial? Eur J Cancer (2010) 0.86
Intravenous magnesium supplementation during cisdiammine-dichloroplatinum administration prevents hypomagnesemia. Ann Oncol (1990) 0.84
Non-specific immunotherapy with bacille Calmette-Guérin (BCG). Clin Exp Immunol (2001) 0.84
Initial risk stratification and presenting characteristics of patients with evolving myocardial infarctions. Emerg Med J (2008) 0.83
A randomized trial of the effects of early cardiac serum marker availability on reperfusion therapy in patients with acute myocardial infarction: the serial markers, acute myocardial infarction and rapid treatment trial (SMARTT). J Am Coll Cardiol (2000) 0.82
Analysis of prognostic factors in disseminated prostatic cancer. An update. Dutch Southeastern Urological Cooperative Group. Cancer (1990) 0.82
Effectiveness in inhibition of recovery of cell survival by cisplatin and carboplatin: influence of treatment sequence. Int J Radiat Oncol Biol Phys (1991) 0.81
The importance of prognostic factors in the individual treatment of patients with disseminated germ cell tumours. Br J Urol (1990) 0.81
Transection of the bladder as a method of treatment in adult enuresis nocturna. Br J Urol (1979) 0.80
Improvement of lesion detection by echographic image processing: signal-to-noise-ratio imaging. Ultrason Imaging (1991) 0.80
Repair of sublethal damage in two human tumor cell lines grown as multicellular spheroids. Int J Radiat Oncol Biol Phys (1989) 0.80
Effectiveness of cis-platin and carboplatin in the chemotherapy of squamous cell carcinoma grown as multicellular spheroids. Anticancer Res (1990) 0.80
Immune reactions in patients with superficial bladder cancer after intradermal and intravesical treatment with bacillus Calmette-Guérin. Cancer Immunol Immunother (1989) 0.79
The effect of familiality on clinical presentation and survival in mammary carcinoma. Eur J Surg Oncol (1987) 0.79
Treatment with desmopressin in severe nocturnal enuresis in childhood. Br J Urol (1990) 0.78
Polyglucosan bodies in intramuscular motor nerves. Acta Neuropathol (1989) 0.78
Radiosensitivity of different human tumor cells lines grown as multicellular spheroids determined from growth curves and survival data. Int J Radiat Oncol Biol Phys (1989) 0.78
Value of biochemical markers in the management of disseminated prostatic cancer. Eur Urol (1992) 0.78
Effect of perioperative blood transfusion and cell saver on the incidence of postoperative infective complications in patients with an aneurysm of the abdominal aorta. Eur J Surg (1992) 0.77
Paternity after bilateral vasectomy. BJU Int (1999) 0.77
BCG-RIVM intravesical immunoprophylaxis for superficial bladder cancer. Prog Clin Biol Res (1988) 0.77
Bacillus Calmette-Guérin in superficial bladder cancer: consensus and controversies. Eur Urol (1995) 0.77
Morphological aspects of the interaction of Bacillus Calmette-Guérin with urothelial bladder cells in vivo and in vitro: relevance for antitumor activity? Urol Res (1992) 0.77
The effects of acute cerebrovascular disease on serum and cerebrospinal fluid parameters. Clin Neurol Neurosurg (1987) 0.77
Chest pain evaluation units: an idea whose time has come. JAMA (1997) 0.77
BCG (RIVM) versus mitomycin intravesical therapy in superficial bladder cancer. First results of randomized prospective trial. Urology (1988) 0.76
Gender and chest pain evaluation. Acad Emerg Med (1995) 0.75
Treatment of carcinoma in situ of the urethra with intraurethral instillations of bacillus Calmette-Guérin. Case report and review of literature. Eur Urol (1991) 0.75
A new method for permanent catheterization in the dog. Urol Res (1983) 0.75
Peritoneal transport kinetics of glucose, urea, and creatinine during infancy and childhood. Perit Dial Int (1991) 0.75
[Testis tumor, an insidious disease]. Ned Tijdschr Geneeskd (1984) 0.75
Effects of isoniazid (INH) on the BCG-induced local immune response after intravesical BCG therapy for superficial bladder cancer. Urol Res (1994) 0.75
Intravesical and intradermal BCG-RIVM application: a toxicity study. Prog Clin Biol Res (1985) 0.75
Impaired immune response by isoniazid treatment during intravesical BCG administration in the guinea pig. Prog Clin Biol Res (1992) 0.75
Radiosensitivity of human melanoma spheroids influenced by growth rate. Int J Radiat Oncol Biol Phys (1990) 0.75
[Long-term application of the percutaneous, suprapubic bladder catheter]. Ned Tijdschr Geneeskd (1983) 0.75
[Study of surgically removed pelvic lymph nodes in the staging of prostatic carcinoma]. Ned Tijdschr Geneeskd (1982) 0.75
Sublethal damage repair in two radioresistant human tumor cell lines irradiated as multicellular spheroids. Tumour Biol (1991) 0.75
BCG-(RIVM) versus mitomycin intravesical therapy in patients with superficial bladder cancer. EORTC GU Group and the Dutch South-East Collaborative Group. Prog Clin Biol Res (1989) 0.75
Effects of long-term catheter implantation on the contractile and histological properties of the canine bladder. J Urol (1985) 0.75
Separation of serum proteins by high-performance gel-permeation column systems. J Chromatogr (1990) 0.75
Astrocytoma in childhood: survival and performance. Pediatr Hematol Oncol (1990) 0.75
A practical guide to the use of intravesical BCG for the management of stage Ta, T1, CIS, transitional cell cancer. Prog Clin Biol Res (1989) 0.75
A new longer-acting LHRH analog depot: preliminary results of a Dutch open phase II clinical study on a 10.8 mg Zoladex 3-monthly depot. Eur Urol (1990) 0.75
Intravesical instillation therapy: alternative treatments. Recent Results Cancer Res (1993) 0.75
New treatment approaches for superficial and invasive bladder cancer. Urol Oncol (2011) 0.75
[Reflex anuria]. Ned Tijdschr Geneeskd (1982) 0.75
Transcapillary ultrafiltration and lymphatic absorption during childhood continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant (1991) 0.75
[Intranasal administration of luteinizing hormone-releasing hormone in the treatment of undescended testis]. Ned Tijdschr Geneeskd (1984) 0.75
Tissue polypeptide-specific antigen (TPS) determinations before and during intermittent maximal androgen blockade in patients with metastatic prostatic carcinoma. Eur Urol (2003) 0.75
[Diagnostic possibilities in Meckel's diverticulum]. Ned Tijdschr Geneeskd (1978) 0.75